Clinical Infectious Diseases · 2019 · 31 citations · 6 references
PharmacyPharmacoeconomicsPharmacotherapyAntimicrobial PharmacotherapyMusculoskeletal InfectionOutpatient Parenteral Antimicrobial TherapyAntimicrobial Agent SelectionAntimicrobial Therapy For Musculoskeletal InfectionBone InfectionsJoint InfectionsOrthopedic InfectionOutpatient Antimicrobial StewardshipBone Infection TherapyOral Antibiotic TherapyOutpatient Antibiotic Prescribing SupportOutpatient Intravenous Antibiotic SelectionOutpatient Parenteral Antibiotic TherapyOutpatient Parenteral Antimicrobial Therapy StewardshipPotential Economic Impact
The OVIVA study demonstrated noninferiority for managing bone and joint infections (BJIs) with oral antibiotics. We report that 79.7% of OPAT patients being treated for BJIs at our center would be eligible for oral antibiotics, saving a median (IQR) 19.5 IV-antibiotic days (8.5-37) and GBP 1234 (569-2594) per patient.
6
Douglas R. Osmon, Elie F. Berbari, Anthony R. Berendt et al. · Clinical Infectious Diseases · 2012 · 2.2K citations · Full text
Oral versus Intravenous Antibiotics for Bone and Joint Infection
Ho Kwong Li, Ines Rombach, Rhea Zambellas et al. · New England Journal of Medicine · 2019 · 900 citations · Full text